Top Stories

The market is underpricing the possibility of a vaccine, Goldman Sachs strategists say

0


French engineer-virologist Thomas Mollet looks at 24 well plates adherent cells monolayer infected with a SARS-CoV-2 virus at the Biosafety level 3 laboratory of the Valneva SE Group headquarters in Saint-Herblain, near Nantes, France, on July 30, 2020.


jean-francois monier/Agence France-Presse/Getty Images

The market is underpricing the possibility of a vaccine, Goldman Sachs strategists say.

Forecasts are assuming a nearly 40% chance of a vaccine being broadly available by the first quarter of 2021, and the strategists, led by Kamakshya Trivedi, say there is a good chance that at…



Source marketwatch.com

Exports and imports in July

Previous article

In Colombia, ‘climate-smart’ villages could show future of farming

Next article

You may also like

Leave a Reply

avatar
  Subscribe  
Notify of

More in Top Stories